VCYT FY 2017 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$72M+10.6% YoY

Gross Profit

$44M60.8% margin

Operating Income

-$27M-36.9% margin

Net Income

-$31M-43.1% margin

EPS (Diluted)

$-0.91

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$26M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$79M

Total Liabilities

$41M

Stockholders' Equity

$37M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72M	$65M	+10.6%
Gross Profit	$44M	$40M	+10.4%
Operating Income	-$27M	-$29M	+7.9%
Net Income	-$31M	-$31M	+1.1%